{
  "report_rows": [
    {
      "kpi": "AST Organic Growth",
      "prediction": "IN-LINE",
      "answer": "pred ~5.5% vs. cons 5.1%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total Organic Growth",
      "prediction": "IN-LINE",
      "answer": "pred ~6.5% vs. cons 6.3%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. Operating EPS",
      "prediction": "IN-LINE",
      "answer": "pred ~$2.53 vs. cons $2.510",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY27 Adj. EPS (FY27)",
      "prediction": "UNCHANGED",
      "answer": "guide $11.10-$11.30 vs. cons $11.17",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY27 Revenue Growth (FY27)",
      "prediction": "UNCHANGED",
      "answer": "guide +7%-+8% vs. cons ~+6.8% implied",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "AST CC Organic Growth (FY27)",
      "prediction": "UNCHANGED",
      "answer": "guide +7%-+8% vs. cons 7.7%",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -3.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -4.5,
  "day5_path": "FADE",
  "day5_rationale": "FADE \u2014 in-line/maintain with no estimate upgrade catalyst; sell-side trims near-term organic growth estimates; buyback support and low beta (0.55) limit downside but do not reverse it",
  "day5_confidence": "MEDIUM"
}